dc.contributor.author
Murtha, Matthew
dc.contributor.author
Esteller, Manel
dc.date.issued
2020-06-18T10:32:45Z
dc.date.issued
2020-06-18T10:32:45Z
dc.date.issued
2016-10-01
dc.date.issued
2020-06-18T10:32:45Z
dc.identifier
https://hdl.handle.net/2445/166226
dc.description.abstract
The advent of functional genomics powered by high-throughput sequencing has given us a new appreciation of the genomic sequences that lie outside the canonical promoter-coding sequence box. These regions harbor distant regulatory elements, enhancers, super-enhancers, insulators, alternative promoters, and sequences that transcribe as noncoding RNAs (ncRNAs) such as miRNAs and long ncRNAs. These functional genomics studies have also enabled a clearer understanding of the role of the 3D structure of the genome in epigenetic regulation. Here we review the impact that epigenetic changes, and specifically DNA methylation, have on these extraordinary sequences in driving cancer progression.
dc.format
application/pdf
dc.relation
Versió postprint del document publicat a: https://doi.org/10.1016/j.trecan.2016.08.004
dc.relation
Trends in Cancer, 2016, vol. 2, num. 10, p. 572-584
dc.relation
https://doi.org/10.1016/j.trecan.2016.08.004
dc.rights
(c) Elsevier, 2016
dc.rights
info:eu-repo/semantics/openAccess
dc.source
Articles publicats en revistes (Ciències Fisiològiques)
dc.title
Extraordinary cancer epigenomics: thinking outside the classical coding and promoter box
dc.type
info:eu-repo/semantics/article
dc.type
info:eu-repo/semantics/acceptedVersion